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Within recent decades, the prevalence of obesity has increased worldwide in conjunction with the practice of sleep curtailment that is often a part of modern society 1. Within the United States alone, more than a third of individuals over the age of 20 are obese, and roughly 25% of children aged 2-11 are considered obese 2. When including those who are overweight, this number reaches nearly 70% of the population over 20 years of age 2. While the United States still ranks among the highest for obesity prevalence, this condition is reportedly on the rise globally in both developed and underdeveloped countries. According to the WHO, obesity prevalence worldwide has tripled since 1975, and as of 2016, 650 million adults and 340 million children were obese 3. Including those who are overweight increases this number significantly. This phenomenon has heightened interest in both researchers and the public, as obesity is associated with a number of comorbidities and a decreased quality of life. When observing the past few decades, global trends have arisen that can be attributed to the increasing prevalence. These include an increase in energy-dense, fatty foods and a decrease in physical activity due to urbanization and the sedentary nature of modern transportation and occupations 3. While many risk factors proposed for obesity have been thoroughly studied in terms of energy intake and expenditure, the inclusion of sleep as a risk factor is novel by comparison. There have been propositions that both the quality and duration of sleep are important in describing this relationship and may even influence energy use 1. While data is not as readily available on global sleep trends, survey studies conducted in the United States and other countries report individuals sleeping less, on average, than previous decades 4. This decrease in sleep has occurred simultaneously with the worldwide increase in obesity, suggesting a temporal relationship. The purpose of this study is to further examine this relationship among an older population of Tobago men by addressing sleep quality and duration and its association with adiposity distribution and obesity. 
 To date, there are a number of studies that have addressed the effect of sleep on weight and other metabolic outcomes, in addition to weight and its effect on sleep. These studies have ranged from cross-sectional survey designs on large populations to lab-based experimental sleep deprivation in a small number of volunteers. Most have attempted to both quantify and describe the pathophysiology and biological mechanisms as to how changes in sleep contribute to obesity and other conditions associated with obesity. While cross-sectional designs have proven difficult for causal inference, they are important nonetheless in contributing to this growing body of knowledge. 
1.1	Differences in sleep and obesity by sex and Age Group
1.1.1	Differences between men and women
The current literature suggests an overall negative affect of sleep deprivation on metabolic health. This has been addressed in both children and adult study populations, including both men and women and different ethnic groups. The results, however, have not been entirely consistent. Though a similar correlation has been found between poor sleep habits and obesity in both men and women, there is evidence that the mechanism through which this occurs is different. A recent randomized cross-over clinical trial addressing shorter sleep duration and hormonal regulation in men and women found that under sleep restriction compared to a habitual eight to nine hours, both ghrelin and total glucagon-like peptide 1 (GLP-1) levels differed by sex 5. Ghrelin levels were only significantly different in men after sleep deprivation, while GLP-1 was only significantly different in women, suggesting that men may be more likely to overeat during sleep curtailment due to an increase in ghrelin and therefore increased appetite, while women may be more likely to overeat due to the lessening of satiety signals 5. Other studies have also seen an increase in ghrelin under sleep restriction in men but not in women. These differences are being considered in recent studies which aim to enroll balanced numbers of men and women in order to stratify by sex. 
1.1.2	Older Adults
Although an association between sleep duration and quality and obesity remains relatively consistent throughout adult studies, this association appears to weaken or become non-existent  when studying older adults 6. A large proportion of studies involving this population rely on subjective measurements of sleep; however, more recent studies have considered the use of actigraphy and other objective measures. This is especially relevant in older populations that report greater fragmented sleep7. Studies with older participants must also consider a higher prevalence of conditions such as sleep apnea or medication use that could confound the association. Despite differing sleep patterns among the elderly in global studies that include both men and women, there still appears to be an association with a sleep duration less than five hours and a higher BMI6. This is also true for those who habitually sleep longer than nine hours6. The Rotterdam cross-sectional study showed that by using actigraphy to quantify and account for sleep fragmentation in an elderly population, small intervals of interrupted sleep were also associated with a higher BMI and obesity in addition to extreme values of short and long sleep7. 
1.2	Ectopic and central adiposity
In addition to studying obesity outcomes in terms of anthropometric measures, recent studies have also examined the effect of sleep curtailment on the distribution of adiposity, especially central adiposity. It has been shown that greater amounts of central fat are associated with poor health outcomes, and it may serve as a better predictor for these outcomes8. These findings make waist circumference an appealing measure to include in obesity studies. Participants in the National Health and Nutrition Health Examination Survey (NHANES) were recently separated into categories based on healthy waist circumferences and BMI. These groups were then assessed for poor health outcomes such as metabolic syndrome and hypertension. The results indicated that waist circumference was an independent predictor for these adverse outcomes9. There also appears to be a relationship with poor sleep and waist circumference independent of BMI. Although further research is needed, shorter sleep duration also appears to be associated with greater amounts of central adiposity, independent of overall body composition8. Ectopic adiposity between muscle and bone may also be related to poor cardiovascular and metabolic outcomes, although this relationship is less understood. Some studies suggest that there is a U-shaped relationship with sleep duration and ectopic fat10. A recent study in older adults over 60 found that long sleep duration (<9 hours per night) was associated with increased amounts of intra-muscular fat10.  These findings are important for older adults, as aging is associated with decreases in bone density and skeletal muscle, and the interaction with intra-muscular fat may be more complex than previously thought10. Further research is needed to understand the specific relationships and underlying mechanisms. 
1.3	Sleep and Obesity in the African Population
In addition to studies among varying age groups, there have been numerous studies conducted among different demographics worldwide. However, these mainly include developed countries such as the United States and Europe. The findings of studies conducted among those of African ancestry are important to consider when addressing the Tobago population. Most of these studies look at sleep duration, but they still suggest an inverse association between short sleep and risk for obesity. Findings from participants in the Jackson Heart Study suggested a similar relationship among African Americans with an emphasis on problems with circadian rhythm regulation11. Although these studies remain consistent with the literature, differing cultural factors need to be considered when studying sleep habits in Afro-Caribbean populations. To date, there is research among this population pertaining to adiposity and other measures of health; however, few involve sleep and its effect on these health measures. One key study involves the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. This cohort is comprised of both men and women aged 45-84 of various ethnicities with no history of cardiovascular disease12. Among these ethnicities are those with African ancestry. This particular study assessed genetic variance in regards to cardiometabolic profile and risk of hypertension and obesity. In Caucasian populations previously studied, a variant rs5068 of the G allele of the atrial natriuretic peptide (ANP) is associated with lower risk of obesity, higher HDL plasma levels, and lower risk for hypertension12. This study sought to find if the same relationship existed among African Americans by genotyping 1631 participants in the MESA cohort with African ancestry for the variant rs5068. They concluded that the association with this variant and a healthier metabolic profile is present in African Americans, especially those with the AG+GG genotypes12. This study helped to provide insight into differences in ethnicity, which is important for the Tobago population. The Coronary Artery Risk Development in Young Adults (CARDIA) cohort is another multi-ethnic study that investigates cardiometabolic outcomes and risk factors. A recent analysis with this cohort also looked at common genetic variants and their relation to cardiometabolic outcomes. PCSK1 variants rs6232 and rs6235 are thought to be associated with obesity in many ethnic groups13. This study used participants from both the CARDIA and MESA cohort to assess this relationship among the American population. Ultimately, they found that only the rs6232 was significantly associated with obesity in European-Americans, but only rs6235 was significant in African-Americans13. These results once again highlight a potential difference in obesity related factors among different ethnicities. However, caution must be taken in applying these results to other populations of with African ancestry, as other factors may contribute to their cardiometabolic profile. 
With regards to fat distribution and obesity, it is known that skeletal muscle fat, which may have an association with type 2 diabetes and other poor metabolic outcomes, is greater among this population than those of European ancestry14. This phenomenon of inter-muscular infiltration appears to increase with age regardless of weight changes15, making it a relevant factor to be accounted for in the Tobago population. It is also known that those of African ancestry are disproportionately affected by type 2 diabetes and obesity16. However, the difference between overall body fat and ectopic distribution, such as skeletal muscle fat, is still somewhat unclear in its relation to the higher rates of metabolic disorders. There is some evidence that higher skeletal fat distribution and the resulting uneven distribution of fat may be significant, especially in elderly African populations17. Although the biologic mechanisms are still unclear, there appears to be an association between higher skeletal fat distribution and all-cause mortality among these individuals18. Despite these proposed mechanisms to explain the higher rates of metabolic disorders, the role of sleep and its association with ectopic fat distribution in this population is vague, as other social stressors, such as racial segregation, may play a role in sleep disturbances. 
1.4	How obesity is measured
There are a number of ways in which obesity is measured within research studies. The most common are anthropometric measures including BMI and waist circumference. BMI is calculated with measurements of height and weight19, while waist to hip ratios can be calculated with separate waist and hip measurements. The waist measurement will occur at the narrowest part of the waist for consistency20. In addition to these simple measures, there are also more complex methods to obtain a crude measure for total body fat, such as dual-energy X-ray absorptiometry (DXA), which has been used in the Tobago population20. This method uses a densitometer to measure bone mineral density, which is known to be affected by obesity 21.  By emitting photons at varying energy levels, the composition of each tissue type can be determined and therefore analyzed separately, providing a composite measure for body composition22. Newer methods involving a half-body analysis have also proven to provide valid measurements. This procedure allows those with a BMI greater than 30kg/m2 to be supported by the scanner, which had been problematic prior to this method due to weight limitations and the width of the scanner22. The newer technique uses the same technology but relies on an estimation based on the half-body measurement22. 
1.4.1	Ectopic fat and adiposity distribution
The measurements for ectopic fat and fat distribution are also more complex than most anthropometric measures. They are also used less frequently in the literature, but provide important insight into the effects of ectopic fat distribution. In order to measure skeletal muscle fat in the periphery, such as the calves, peripheral quantitative computerized tomography (pQCT) is most frequently used because it can assess muscle and fat density and is also proven to be sensitive to changes in these densities23. This method is also less invasive and emits less radiation than other methods used, such as a CT scan23. To further assess total skeletal muscle fat, it can be further delineated by studying intermuscular fat within the fascia and intramyocellular fat, which is within the muscle cells20. However, muscle density is an appropriate measure for both because a lower muscle density is associated with higher fat infiltration, both within the fascia and myocytes24. For more complete information on fat and total body composition, studies using these measurements will often use additional DXA measures.  Skeletal muscle fat is one of many measures of ectopic adiposity. Studies focused on fat distribution have also addressed visceral, liver, and pericardial fat and its potential association with negative metabolic outcomes. Recent research has suggested that high amounts of visceral fat may be more significant than subcutaneous fat in the etiology of certain metabolic diseases, cancer, and all-cause mortality25. In participants selected from the Framingham Heart Study, Fox et al. used computed tomography to assess both visceral and subcutaneous abdominal fat, finding that visceral fat had a stronger association with adverse metabolic outcomes than the subcutaneous type, even after adjusting for BMI25. Since visceral abdominal fat is a tissue capable of releasing hormones and other pathogenic molecules26, it is important to be able to distinguish it from other fat types with appropriate measurement tools. For specific measures of visceral abdominal fat, methods such as DXA may not be as effective, as they prove difficult to differentiate between deposits of adipose tissue27. The preferred method for abdominal visceral fat measurement is the CT scan and MRI. These methods are capable of distinguishing between different tissue and can provide detailed resolution28. Both CT and MRI may be limited in accuracy when addressing abdominal fat volume since single-slice images are typically used; however, this is done to reduce cost and participant exposure to radiation28. When volumetric analysis needs to be considered, Kobayashi et al. found that using BMI as a surrogate for visceral abdominal fat measurements may be appropriate28. In the absence of high cost and radiation exposure, multiple-slice MRI images are considered best for volume measures, yet CT appears to be more readily available29. To provide a quicker measure of visceral and subcutaneous fat, ultrasound is another method that is often employed, especially for assessing intra-abdominal adiposity30. While not measured directly, methods exist to estimate visceral abdominal fat through an abdominal fat index derived from ultrasonography31. Although its reliability is in question, it is still used for a faster, convenient measure of body composition and visceral adiposity.  
1.4.2	Pericardial and liver fat
In addition to abdominal visceral fat, pericardial and liver fat are also measured using CT. Oftentimes these measurements can be confirmed with an MRI. For pericardial fat measurements, it must be differentiated from epicardial fat, which is often assessed by use of echocardiohraphy32. This method is often not useful for pericardial fat unless epicardial fat is being used as a surrogate measure32.  Therefore, the CT scan and MRI are most widely used, although it may be difficult to discern the pericardial fat in lean individuals33. 
To quantify fat in the liver, MRI is also commonly used as it is sensitive to smaller amounts of liver fat in addition to volumetric measures of adiposity34. Similarly, Magnetic Resonance Spectroscopy (MRS) uses a similar non-invasive method to quantify fat in the liver and is considered the most accurate method to do so35. However, with cost and time constraints, it is not the most widely used tool for liver fat measurement. Similar to other ectopic measures, CT is often used for the liver, where fat can be measured with x-ray attenuation36. Ultrasound is another common tool utilized, but its validity is inconsistent and dependent on the operator. It has also proven to be difficult to use on extremely obese patients since the liver becomes increasingly difficult to penetrate and visualize37. Finally, a percutaneous liver biopsy can be used to measure liver fat, which can include the size of fat droplets38. Since the liver is not always homogeneous in fat distribution, sampling bias may result in an underestimation or overestimation of total liver fat38. Current research has suggested the use of non-invasive biomarkers to reduce within-tissue variability and inaccuracy in other measurements.

1.4.3	Surrogate measures
Though not a direct measure of obesity and adiposity, it is important to consider other measures that may act as a surrogate for obesity and cardiometabolic outcomes. When conducting studies to determine a relationship between sleep and obesity, some use outcomes such as energy intake and expenditure and glucose homeostasis. There have also been studies that measure hunger and satiety hormones. Calorimetry is a common method to analyze energy intake and expenditure, while blood samples are often taken for glucose levels and other biologic indicators of metabolic function39. An intravenous glucose tolerance test is also used to study insulin and glucose relationships40. Other studies have taken biopsies of subcutaneous fat to use the adipocytes for experimentation and assess their response to insulin, though this approach is more costly and used less frequently41. There are numerous other methods to quantify outcomes that can possibly predict or promote obesity; therefore, they are also considered when used in sleep studies, especially those that aim to discover the biological mechanisms behind the association. 
1.5	How sleep is measured
Among the studies that have sought to explain the association between inadequate sleep and obesity, there have been various methods used to measure sleep. While most measures of obesity were objective in nature, more subjectivity is present when quantifying sleep length and quality due to the self-report measures often employed. For study designs involving multiple populations or countries, methods such as surveys, sleep diaries, and phone interviews are often used and are sometimes subject to reporting bias6. This is especially true when used for older populations that may experience more fragmented sleep or memory decline7. These measures are also limited when addressing daytime naps, which are often not included in the questionnaires or prove more difficult to remember their duration42. 
1.5.1	Objective measures
More recent longitudinal studies have incorporated more objective measures to quantify sleep duration and quality. Duration is commonly measured with actigraphy, which can monitor and estimate sleep patterns through algorithms with a relatively high level of accuracy43. Many actigraphs are worn on the wrist and is capable of measuring movement, which is used to estimate circadian rhythms and quantify time spent in deep and light sleep43. Issues with validity have been addressed with actigraphy due to the way the onset of sleep is measured. A lack of movement for a prolonged period of time is often sufficient for the device to begin measuring sleep, therefore overestimating sleep duration43,44. It then underestimates wakefulness spent lying in bed, which often occurs before falling asleep or from bouts of wakefulness in participants with insomnia43. This highlights an important difference between measurements of sleep duration and sleep quality. Actigraphy is often accurate for measuring duration, but problems arise when measuring quality or sleep efficiency since they do not account for wakefulness throughout the night43. Despite these limitations, Marino et al estimated the devices to be about 86% accurate with very high in sensitivity (96%) for healthy adults with nocturnal sleep patterns43. BodyMedia’s SenseWear® Pro Armband is a validated actigraph often cited in the literature that is capable of measuring both sleep and physical activity45. Wirth et al used this device to determine if poor sleep efficiency was associated with a higher BMI45. This study not only demonstrated a relationship with poor sleep quality and a higher BMI, but did so through a newer non-invasive method that can potentially be used for obesity interventions45. A limitation of this device is that it is most accurate within a range of temperatures46. Therefore, caution must be taken when using the device in a home setting, where temperatures may be more variable than a lab setting. Within Marino et al’s study, they also compared actigraphy to polysomnography, which is considered the gold standard for measuring sleep. Since it measures multiple physiological elements of sleep such as brain activity, eye movements, and muscle activity, it provides the most accurate assessment of circadian rhythms, wakefulness, and sleep duration43. Although actigraphy cannot replicate the accuracy of polysomnography, it is deemed appropriate and practical for studies where participants cannot be in a laboratory setting, and may even provide a more realistic assessment of sleep patterns in a setting comfortable to the participant, rather than a setting which may disrupt their normal sleep and promote participant burden43. Due to limitations in sleep efficiency assessment, actigraphy assessments are often coupled with a self-report measure, such as a sleep diary, for comparison. This provides better insight into how participants perceive their quality of sleep to be47. 
1.6	Proposed mechanisms
1.6.1	Endocrine regulation
There have been a number of mechanisms proposed to explain the biological mechanism behind the association with sleep curtailment and obesity. Many of these hypotheses focus on changes glucose metabolism, appetite, and energy expenditure. These hypotheses can become even more complex when one considers their potential interactions. It has been shown that both partial and total sleep deprivation can increase activity in the central nervous system due to the orexin neuropeptide, as the body is under stress and increases cortisol levels48. This phenomenon can reduce glucose tolerance and consequently increase insulin resistance, resulting in metabolic complications that have been associated with obesity48,49. This pathway is important for obesity studies since orexin is also associated with sleep and wakefulness48. In many human laboratory studies, sleep was restricted to extremely low amounts of time, if any, which is less common among the population. Restriction to 5 to 6 hours per night was found to be a more appropriate cutoff to study the effects of short sleep50. These studies have been less consistent in their hormone measurements and suggest that cortisol may not be as significant when sleep was only restricted to 5 hours51. There were, however, more significant changes in catecholamine, which can have similar effects on changes in insulin and glucose51. Effects on glucose tolerance have been studied with short sleep duration, but they have also been addressed in terms of sleep quality. By interrupting participants sleep throughout all stages of deep and light sleep, Stamatakis et al. showed that sleep fragmentation is also associated with a decrease in insulin sensitivity and glucose tolerance and increases in sympathetic nervous system activity52. It is therefore important to consider the effects of insomnia and sleep-disordered breathing on this association, as it may be a cause of sleep fragmentation52. 
1.6.2	Appetite regulation
Shorter sleep duration and poor sleep quality may also have an adverse effect on appetite regulation. As with studies addressing glucose and insulin levels, studies on appetite regulation often show more extreme results when total sleep deprivation is a part of the intervention. Spiegel et al., found that two days of partial sleep restriction with controlled physical activity and caloric intake resulted in an 18% decrease in the hormone leptin, which is involved in satiety, and a 28% increase in the hormone ghrelin, which signals hunger53. Though these hormones fluctuate throughout the day and vary based on energy intake, they are also modified by changes in sleep.  Leptin has been shown to reach a maximum level during sleep, while increases in ghrelin also tend to occur, likely as a rebound from former food intake from evening meals54. Despite fasting throughout the night, ghrelin levels will eventually decrease during the latter portion of the sleeping period in healthy individuals54. When this cycle is interrupted by sleep curtailment and fragmentation, feelings of increased hunger by self-report have been noted, especially for foods with higher carbohydrate content53. With the assumption that this increase in appetite leads to increased food consumption, the current literature suggests that it is a plausible explanation for the association of sleep curtailment with obesity. When sleep was restricted to four to five hours, increases as high as 22% in caloric intake were observed, owing this increase to changes in hunger and satiety hormones55. 
In addition to greater energy intake, shorter sleep duration is also thought to change the distribution of eating throughout the day, with greater increases in snacking seen at night without significant changes in calories consumed for meals56. Though shorter sleep duration leads to more wakeful hours and potentially greater energy expenditure, Nedeltcheva et al found that this excess energy expenditure was not enough to balance out the increased energy intake56. They noted that the majority of excess calories consumed compared to days wake time following a full night of sleep were from snacks56. Some have suggested that more wakeful hours leave more opportunity to consume more calories, which, in turn, may sustain wakefulness57. It must also be noted that more wakeful hours do not necessarily result in greater energy expenditure. Those who have undergone experimental sleep restriction experienced fatigue during the following day, resulting in less physical activity and energy expenditure58. This leads to other issues that may confound the association between poor sleep and obesity, such as lack of motivation due to fatigue and heightened emotional stress, which can cause excess calorie consumption in some individuals59. However, it appears that energy is more significantly affected by excessive caloric intake compared to decreased energy expenditure through physical activity57. Figure 1 shows a simplistic summary of the proposed pathway.
1.6.3	Limitation and considerations
Although these proposed mechanisms are ubiquitous in the literature, there are important limitations to consider. There are many covariates that have been shown affect the quantity and quality of sleep and should be accounted for. These include factors such as alcohol and caffeine consumption, menopausal status, and leisure physical activity19. Demographics must also be considered. In the SWAN sleep study, Appelhans et al found that African Americans were almost twice as likely to have a higher BMI as an outcome than Asian and Caucasians in a cross-sectional analysis19. Also, African Americans adults tend to report shorter sleep duration, often less than 6 hours per night, compared to Caucasians who were considered short sleepers 60. Information on different demographics is relevant in an area such as Tobago. These findings were also independent of sleep-disordered breathing, which is another covariate that is often not controlled for19. This has important consequences for interpretation of results, as sleep-disordered breathing can lead to insomnia and cause sleep fragmentation52. Additionally, since cross-sectional studies cannot demonstrate temporality, it has been suggested that obesity can lead to issues with sleep, or it may act as mediator for other outcomes61. A final consideration is the effect of epigenetic factors and obesity risk. There are several hypotheses suggested that early fetal exposures, such as stress and other environmental factors, can alter the epigenome 62. These genetic changes are thought to predict obesity later in life. More research is needed to fully describe the mechanisms for this relationship. It should therefore be noted that the rapid change in sleep habits and obesity cannot be solely explained by changes in diet and lifestyle and requires a multi-faceted approach to understand the full mechanisms behind this relationship. 
1.7	Public Health significance
While studies have included those of African ancestry, the research is limited for Afro-Carribbean populations, who are exposed to different environmental and social influences than those in the United States or other developed countries. This population also experiences different risks for cardiometabolic outcomes since they demonstrate greater skeletal muscle fat infiltration and higher rates of type 2 diabetes and obesity compared to other populations18.  While mechanisms have been proposed to explain the association, further research is needed to explain the disparity. On the island of Tobago, race is nearly homogeneous, with African ancestry accounting for 97% of the population63. Additionally, this population experiences similar environmental and sociocultural factors that can influence sleep duration and quality. Given that this population often reports significantly fewer hours of sleep than other ethnicities, further investigating the relationship between sleep and obesity in this population can lead to interventions that are appropriate and useful for this demographic. This could ultimately have greater public health significance in the global realm, where new information can be useful for similar populations and demographics. 
2.0 	Objective
The objective of this analysis is to explore the association between sleep duration and sleep quality as behavioral exposures and obesity, body fat distribution, and ectopic fat as outcomes. Mean sleep duration will be analyzed by categories of sleep time, while sleep quality will be analyzed by sleep efficiency. For this investigation, it was hypothesized that shorter sleep duration (<5 hours per night) would have higher mean measures of obesity than longer sleep duration.  It was also hypothesized that stronger inverse correlations would exist between poor sleep efficiency and measures of obesity compared to better sleep efficiency. 
3.0 	Methods
3.1	Data collection methods
3.1.1	Anthropometric and lifestyle data
During visits to the island, standardized interview questionnaires were administered at the site clinics to collect information on demographics, medical history, and lifestyle factors, such as smoking habits64. Smoking was categorized into never, former, or current smoker. Men who were not currently smokers but had smoked more than 100 cigarettes were defined as former smokers. To assess alcohol consumption, four or more drinks per week over the past year was considered regular consumption. Serum glucose levels (≥126 mg/dl) or use of diabetic medication were the criteria used to define diabetes. Self-report was used to collect information on other comorbidities such as cardiovascular disease and cancer. To address diet, participants completed a food-frequency questionnaire with items pertaining to specific nutritional intake, such as daily sodium. To obtain more accurate measures of medical history, participants were asked to bring recent prescription medications, which were recorded by the interviewer and further classified using the WHO ATC/DDD drug use classification system (Anatomical, Therapeutic, Chemical classification system with Defined Daily Doses)65. The medications included were those for hypertension, diabetes, and lipid modification. 
For basic anthropometric measurements, standing height and waist circumference were measured twice using a wall-mounted stadiometer and flexible tape65. They were averaged to the nearest 0.1cm. Weight was measured with a balance beam scale and measured to the nearest 0.1kg. Weight and height were then used to calculate body mass index (BMI) (kg/m2). Table 1 provides general characteristics of this population.
3.1.2	Adiposity assessment
In order to measure adiposity, abdominal CT and peripheral  quantitative CT were used. The abdominal CT was used to collect measurements on abdominal subcutaneous adipose tissue (SAT) abdominal visceral adipose tissue (VAT) and liver attenuation. The peripheral quantitative CT was used to collect measures on calf intermuscular adipose tissue (IMAT) and muscle density as a measure of intra-muscular adipose tissue65. SAT and VAT were obtained from cross-sectional images between L3 and S1. To assess liver attenuation, Hounsfield units (HU) were used from 3 contiguous scan slices taken from the T12 to L1 region. The peripheral quantitative CT used for calf IMAT was Stratec XCT-2000 scanner (Orthometrix, Inc.; White Plains, NY). The site used was at 66% of the calf length proximal to the terminal end of the tibia. This is because it has the largest circumference and least variability among individuals65.  All images obtained were analyzed by a trained investigator with STRATEC software, version 5.5D (Orthometrix, Inc.; White Plains, NY). The investigator was not aware of the participant’s vascular calcification status65. 
3.1.3	Sleep assessment
In order to quantify sleep duration and quality, objective measures were used. For physical activity, participants were told to wear the SenseWear® Pro Armband (BodyMedia, Inc., Pittsburgh, PA, USA) for 4-7 days at all times except when bathing or in water. It was worn over the triceps on the upper arm and uses algorithms in the software to calculate measurements of activity. Specifically, it measures acceleration, heat flux, skin temperature, galvanic skin response, total sleep time, and percent of time spent in each phase of sleep. To asses other measures such as average walking hours, a cutoff point was set at 75% to ensure that data was only included for those who wore the device at for least 18 hours per day. 
3.2	Statistical analysis
The analysis conducted first tested differences in means between sleep duration categories and measures of adiposity by way of one-way ANCOVA using SAS version 9.3 (Proc GLM). Age and lifestyle factors, such as smoking and physical activity were adjusted for, as they have been shown to be potential confounders. This also included TV watching and alcohol consumption. An ANCOVA model was also created only adjusting for age. Additionally, the tests were run controlling for age, lifestyle factors, and BMI to determine what effect, if any, BMI had on the relationship. Measures of adiposity included BMI, waist circumference, pericardial fat, abdominal subcutaneous fat, visceral fat, liver attenuation, calf inter-muscular fat, and calf density. The variables were not normally distributed as determined by the Shapiro-Wilk test for normality (p<0.05), and the sample size across categories of sleep duration was unequal. Therefore, appropriate nonparametric statistical tests were conducted. The Scheffe test for multiple comparisons were also run as a post-hoc test among group means to test for significant differences. 
 To explore the relationship between adiposity with sleep quality, sleep efficiency was calculated as a percent. A test of correlation (Spearman) was conducted between the previously mentioned measures of adiposity and both percent sleep efficiency and total sleep time in hours. Partial spearman correlation coefficients were obtained after controlling for age and lifestyle factors (smoking status, physical activity, TV watching, and alcohol consumption). The alpha level of significance was set at 0.05 for all analyses.
4.0 	Results
4.1	General Characteristics
The mean age of men in this sample was 62.7+/-8 years (range: 50-89 years). Based on average BMI, participants were overweight, but not obese (BMI=28.06+/-4.6 kg/m2) (range: 18.1-42.8 kg/m2). Roughly 31% of participants were obese as defined by a BMI>30 kg/m2 and 22% had type 2 diabetes. The average sleep duration in this population is 5.26 hours. See Table 1 for general cohort characteristics. 
4.2	Relationship among adiposity measurements with sleep duration
After conducting the hypothesis tests for differences in means among categories of sleep duration and measures of adiposity adjusting for age and lifestyle factors, the mean differences among groups were not statistically significant for any variable at alpha=0.05. However, there are important trends to be noted, as some measures of adiposity displayed a trend toward significance. A borderline significant negative trend with sleep duration is present in means for calf muscle density (p=0.069) and visceral fat (p=0.097). Both measures show highest adiposity means in the groups that sleeps less than 5 hours per night and the lowest means in the 5-7 hours per night group. Despite non-statistically significant results, BMI, waist circumference, abdominal subcutaneous fat, and calf intermuscular fat means were highest in the less than five hours per night category. Pericardial fat mean was highest in the greater than seven hours per night group. No trend was apparent for liver attenuation. The tests for pairwise comparisons were not significant. See Table 2 for results. 
The ANOVA test controlling for age only yielded similar results. Though none of the tests for mean differences were statistically significant, visceral fat was borderline significant (p=0.076). However, unlike the adjustment for lifestyle, this model did not have a borderline significant result for calf density (p=0.142). Once again, measures of adiposity appeared to be highest in the group that slept less than five hours per night. 
The ANOVA test controlling for age, lifestyle, and BMI also did not produce statistically significant results. Additionally, none of the group means were significant. Visceral fat, which had the lowest p-value in the other models, had a p-value of 0.616 in this model. Measures of adiposity appeared highest in the group sleeping less than five hours per night, with the exception of pericardial fat, which was once again highest in the group sleeping greater than seven hours per night.  
4.3	Correlation of adiposity with sleep quality
After determining the unadjusted correlation coefficient for each adiposity variable with total sleep time and sleep efficiency adjusting for age and lifestyle, a number of the measures yielded a significant correlation. Total sleep time was negatively correlated with BMI (r=-0.170, p=0.017), waist circumference (r=-0.200, p=0.005), abdominal subcutaneous fat (r=-0.157, p=0.027), and calf intermuscular fat (r=-0.168, p=0.018). Total sleep time and calf density had a positive correlation (r=0.230, p=0.001). Sleep efficiency was also negatively correlated with BMI (r=-0.166, p=0.019), waist circumference (r=-0.237, p<0.001), abdominal subcutaneous fat (r=-0.208, p=0.003), and calf intermuscular fat (r=-0.126, p=0.078). There was no significant correlation with calf density. Additionally, sleep efficiency was also negatively correlated with pericardial fat (r=-0.160, p=0.024) and visceral fat (r=-0.153, p=0.032). Liver attenuation was the only measure that did not produce a significant correlation with either total sleep time or sleep efficiency; however, there was a borderline positive correlation between sleep efficiency and liver attenuation (r=0.123, p=0.083). The correlations observed were weak, as all were less than 0.3. See table 5 for results. 
5.0 	Discussion
Exploratory analyses were conducted to determine a relationship, if any, among various measures of adiposity and sleep quality and duration in a Tobago Afro-Carribbean population. The general characteristics of this cohort represent a sample of this population, which demonstrates unusually low hours of sleep duration and a high percentage of obesity and diabetes. Although genetic variation may play a role in these disparities, it is important to consider other factors, such as older age and subsequently less physical activity, which may contribute to the high rates of obesity. Also, although this population is known to have greater amounts of skeletal muscle fat, which is thought to contribute to type 2 diabetes, less is known about their habitual sleep curtailment. Given that this is an older population, daytime naps were often reported. Although this did not contribute to the total sleep time, which was calculated from nighttime sleep hours, the periodic napping could explain the shorter sleep duration at night. Also, sleep disordered breathing is known to disrupt both sleep duration and efficiency, which may contribute to an explanation for their short sleep duration.
  When testing for differences among mean adiposity measures and sleep duration with different degrees of adjustment for covariates, we observed the strongest evidence of a correlation in the model that adjusted for age and lifestyle factors (smoking status, physical activity, TV watching, and alcohol consumption) but not for body mass index (BMI). Age and lifestyle are plausibly operating as confounders. BMI is associated with the adiposity-related anthropometrics and therefore is potentially downstream of the outcome and should not be adjusted for.  In a spearman rank test that does not assume linearity in the relationship, we observed consistent negative correlations between sleep efficiency (treated as a continuous variable) and sleep duration and higher tissue specific adiposity.  Two of these measures were positively correlated with sleep, which could suggest that they are proxies of healthy organ function (liver attenuation and calf muscle density).  Overall, we found preliminary evidence of a negative correlation between sleep duration and the risk of tissue-specific obesity.  However, inference is limited by sample size and the possibility for unmeasured confounding and non-linearity in these relationships that may have a basis in neuroendocrine mechanisms. 
The literature is consistent with these findings, since sleep curtailment is thought to contribute to increases in ectopic fat25,66.  Other studies have also reported greater skeletal muscle fat infiltration in this population compared to those of European descent, making it plausible that greater volumes of skeletal fat would be seen as a result of poor sleep14. There was also indication that sleeping less than five hours per night was associated with greater amounts of both ectopic and overall fat than other sleep categories. This trend was apparent in all three adjusted models. Calf inter-muscular fat, in particular, seemed to be affected by sleep duration, as there was nearly a 14% decrease in adiposity for those who slept more than seven hours compared to those who slept less than five. In the model also adjusting for BMI, the borderline significance seen in the other models was no longer present for visceral adiposity. This may suggest that BMI is an important confounder when addressing sleep and visceral fat. It is also important to note that the highest means for pericardial fat were present in the group sleeping greater than seven hours per night. Given that excess sleep has been shown to be associated with certain cardiac outcomes33, it is plausible that excess sleep may contribute to excess pericardial fat in this population. Additionally, pericardial fat has a negative correlation with sleep efficiency, further suggested that poor sleep can contribute to excess fat in this region. These trends toward significance may be due to the smaller sample size of the cohort.
Many significant correlations were produced for adiposity and sleep efficiency. These correlations were negative, suggesting that low or poor sleep efficiency is associated with higher measures of mean adiposity. The strongest correlation was seen with sleep efficiency and waist circumference. Poorer sleep efficiency is correlated with greater waist circumference in this study. Meta-analyses have suggested that this correlation is also plausible, since fragmented sleep has been associated with greater overall adiposity8. Additionally, some measures of adiposity were only correlated with sleep efficiency, not total sleep time. These included pericardial fat, visceral fat, and liver attenuation. Pericardial and visceral fat yielded a negative correlation, while liver attenuation was positive. Pericardial and visceral outcomes were also of interest for the sleep duration tests, as previously mentioned. These results may indicate that sleep duration and quality are important for overall body composition, but also for adiposity distribution, especially central adiposity. While numerous studies have explored sleep quality and obesity, those looking at liver attenuation are sparse. Therefore, the mechanism behind this correlation remains unclear. 
There are several strengths to be noted in this study, perhaps the greatest being the use of objective measures to capture sleep time and quality. This helped to eliminate recall bias that is often introduced in questionnaires and interviews about sleep. Also, quality measures were used to collect data on adiposity, including pQCT, which is sensitive to collecting information on muscle density. Additionally, the study design is ongoing with the same cohort, therefore appropriate follow-up can be conducted. The study also represents a strong sample size, given the population of the island. Given what is known in the literature about aging, sleep, and obesity, the target population is appropriate.
There are also important limitations of this study. While the cohort is homogeneous with regards to race, it also includes middle-age and older men, meaning any findings cannot necessarily be generalizable to younger individuals and women on the island. Findings also cannot be generalized to other regions of the world, as this island population may have different environmental and cultural factors contributing to the relationships discovered. There is also the potential for attrition bias, since the study is ongoing. Some participants may have been lost to follow up due to development of a condition such as type 2 diabetes. If this loss to follow-up was differential by their adiposity status, then the bias would likely have been towards the null.  In terms of the statistical analysis, there may be residual confounding that was unaccounted for. There was also incomplete data for some of the variables, which resulted in some individuals being dropped from the analysis and loss of power. 
Further studies are needed to understand the possible mechanisms behind sleep quality and duration, and specific distribution of adiposity. More in depth analyses can be conducted for central adiposity and other ectopic fat deposits in this population. These studies are also needed in women and younger populations to determine if factors such as sex and age differ in regards to adiposity and obesity. Results of these findings could be used to predict certain metabolic outcomes and obesity, and may provide insight into prevention methods. Since the Tobago population is not studied as frequently as other populations of African descent, findings could have important implications for the understanding of obesity and metabolic diseases in a population who already exhibit different rates of diabetes and myosteatosis than other populations. Also, their habitually shorter sleep duration compared with other populations may be an important issue to be targeted for intervention. These analyses suggest that it may even be more urgent to improve sleep efficiency in this population, as it is significant in most adiposity measures. Further research into this topic could contribute to global health since appropriate interventions can be better tailored to this understudied population. 
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Table 1. General characteristics of 348 men in the sleep pilot study
	Mean or N (%)
Age	62.8 ± 7.9
BMI (kg/m2)	28 ± 4.7
Waist (cm)	99.06 ± 12.64
Lifestyle 	
Hours Walked per Week b	3.1 ± 4.18
TV Watching (≥14 hrs/week) c	46.97%
Current Smoker	9.22%
1+ Alcoholic Drinks / Week	36.21%



















Table 2. Results of one-way ANOVA test for difference in means for each category of sleep duration adjusted for age and lifestyle factors

























Table 3. Spearman correlation coefficient and p values for adiposity and total sleep time and efficiency adjusted for age and lifestyle factors

	Total Sleep Time	Sleep Efficiency (%)
BMI	r = -0.170p = 0.017	r = -0.166p = 0.019
Waist	r = -0.200p = 0.005	r =  -0.237p <0.001
Pericardial fat	r = -0.045p = 0.531	r = -0.160p = 0.024
Abdominal Subcutaneous fat 	r = -0.157p = 0.027	r = -0.208p = 0.003
Visceral Fat	r = -0.100p = 0.159	r = -0.153p = 0.032
Liver attenuation 	r = 0.107p = 0.135	r = 0.123p = 0.083
Calf inter-muscular fat	r = -0.168p = 0.018	r = -0.126p = 0.078
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